You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Erenumab

Showing 1 - 25 of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hemicrania Continua Trial in Scottsdale (Erenumab)

Terminated
  • Hemicrania Continua
  • Erenumab
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 6, 2023

Migraine Trial in Copenhagen (Calcitonin Gene-Related Peptide, Erenumab)

Recruiting
  • Migraine
  • Calcitonin Gene-Related Peptide
  • Erenumab
  • Copenhagen, Glostrup, Denmark
    Danish Headache Center
Oct 21, 2022

Migraine Without Aura Trial in Copenhagen (Levcromakalim, Placebo)

Recruiting
  • Migraine Without Aura
  • Copenhagen, Denmark
    Danish Headache Center
May 25, 2023

Migraine Without Aura Trial in Copenhagen (Sildenafil, Placebo)

Recruiting
  • Migraine Without Aura
  • Copenhagen, Denmark
    Danish Headache Center
May 25, 2023

Migraine Trial in Scottsdale (Erenumab)

Completed
  • Migraine
  • Erenumab
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Aug 8, 2022

Aimovig Pregnancy Exposure Registry

Recruiting
  • Migraine
  • Durham, North Carolina
    IQVIA Virtual Site
Nov 21, 2023

Trigeminal Neuropathy Trial in Baltimore (Erenumab-Aooe, Placebo)

Terminated
  • Trigeminal Neuropathy
  • Baltimore, Maryland
    University of Maryland, School of Dentistry, Brotman Facial Pain
Dec 11, 2022

Facial Pain, Rhinosinusitis Trial in Durham (Erenumab Prefilled Syringe, Placebo)

Recruiting
  • Facial Pain
  • Rhinosinusitis
  • Erenumab Prefilled Syringe
  • Placebo
  • Durham, North Carolina
    Duke University Medical Center and affiliated practices
Jun 23, 2022

Schwannomatosis, Schwannomas, Pain, Chronic Trial in Boston (Siltuximab, Erenumab-Aooe, Siltuximab Matching Placebo)

Not yet recruiting
  • Schwannomatosis
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 5, 2023

Erenumab on Sick-leaves, Health Care Resource Use and

Completed
  • Migraine
  • Erenumab
  • East Hanover, New Jersey
    Novartis Investigative Site
Jun 29, 2022

Status Migrainosus Trial in Phoenix (Erenumab)

Withdrawn
  • Status Migrainosus
  • Erenumab
  • Phoenix, Arizona
    Mayo Clinic in Arizona
Feb 4, 2022

MIDAS Reduction at 3 Months for Erenumab Treatment

Completed
  • Migraine
  • Erenumab 70/140 mg s.c.
  • Pavia, Italy
    Headache Science & Neurorehabilitation Center
Jun 28, 2022

Migraine, Headache Trial in Copenhagen (Erenumab)

Recruiting
  • Migraine
  • Headache
  • Erenumab
  • Copenhagen, Denmark
    Danish Headache Center
Dec 18, 2021

Temporomandibular Disorder Trial in Indianapolis (Erenumab-aooe (EREN) 140 mg s.c. administered every four weeks for a total of

Recruiting
  • Temporomandibular Disorder
  • Erenumab-aooe (EREN) 140 mg s.c. administered every four weeks for a total of five treatments
  • Placebo (EREN-P) s.c. administered every four weeks for a total of five treatments
  • Indianapolis, Indiana
    Indiana University School of Dentistry, Oral Health Research Ins
Mar 17, 2022

Posttraumatic Headache, Mild Traumatic Brain Injury Trial in Fort Bragg, Jacksonville, Fort Sam Houston (Erenumab 140 Mg/mL

Recruiting
  • Posttraumatic Headache
  • Mild Traumatic Brain Injury
  • Erenumab 140 Mg/mL Subcutaneous Solution
  • Placebo
  • Fort Bragg, North Carolina
  • +2 more
Jun 16, 2022

Cluster Headache, Trigeminal Autonomic Cephalalgias, Headache Disorders, Primary Trial in Germany (Erenumab, Placebo)

Recruiting
  • Cluster Headache
  • +3 more
  • Erenumab
  • Placebo
  • München, Bayern, Germany
  • +6 more
Nov 19, 2021

Migraine Disorders Trial in Italy (erenumab, )

Completed
  • Migraine Disorders
  • erenumab
  • placebo
  • Milano, MI, Italy
  • +4 more
Aug 12, 2021

Migraine Trial in L'Aquila (Blood sampling for microRNA testing)

Recruiting
  • Migraine
  • Blood sampling for microRNA testing
  • L'Aquila, Italy
    University of L'Aquila
Jul 1, 2021

Migraine Trial in United States (Erenumab)

Recruiting
  • Migraine
  • Erenumab
  • Huntsville, Alabama
  • +41 more
Feb 1, 2023

Migraine Trial in Worldwide (Erenumab Dose 1, Erenumab Dose 2, Erenumab Dose 3)

Recruiting
  • Migraine
  • Erenumab Dose 1
  • +3 more
  • Aurora, Colorado
  • +88 more
Feb 1, 2023

Neurophysiological, Biomolecular and Psychological Aspects of

Unknown status
  • Chronic Migraine
  • Erenumab
  • Pavia, Italy
    IRCCS Mondino Foundation
Apr 15, 2021

Migraine Trial in Los Angeles, Newport Beach, Waterbury (Galcanezumab, Erenumab)

Completed
Has Results
  • Migraine
  • Los Angeles, California
  • +2 more
Feb 23, 2022

Migraine Trial in Worldwide (Erenumab Dose 1, Erenumab Dose 2, Erenumab Dose 3)

Recruiting
  • Migraine
  • Erenumab Dose 1
  • +3 more
  • Aurora, Colorado
  • +82 more
Dec 6, 2022

Migraine, Migraine With Aura, Migraine Without Aura Trial (Erenumab, Fremanezumab, Galcanezumab)

Recruiting
  • Migraine
  • +4 more
  • Erenumab
  • +2 more
  • Innsbruck, Tirol, Austria
  • +2 more
Oct 19, 2022

Migraine Using Enerumab and Traditional Therapy at Time of

Completed
  • Migraine Disorders
  • Erenumab
  • Fayoum, Egypt
    Marwa Kamal Ahmed Tolba
Sep 17, 2021